source
- Compass Pathways leads race for first psychedelic drug approval, non-profit rivalsCompass Pathways is widely viewed as a leading candidate to bring the first psychedelic medicine to market. The company has advanced its therapy through clinical development and is positioned near…
- Stakeholders submit over 500 comments urging FDA to shape regulation of generative AI medical devicesOver 500 comments have been filed in response to the FDA's discussion paper on generative AI-enabled medical devices. The feedback reflects a wide range of viewpoints. Some participants recommend…